U.S. markets closed

Taro Pharmaceutical Industries Ltd. (TARO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
77.13+0.98 (+1.29%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Total Revenue
601,107
644,769
669,893
661,913
879,387
Cost of Revenue
238,160
245,044
224,169
198,405
208,136
Gross Profit
362,947
399,725
445,724
463,508
671,251
Operating Expense
634,133
153,190
149,531
160,498
156,300
Operating Income
-271,186
246,535
296,193
303,010
514,951
Net Non Operating Interest Income Expense
31,330
33,644
33,542
19,934
14,468
Other Income Expense
10,103
17,856
27,119
-30,576
31,379
Pretax Income
-229,753
298,035
356,854
292,368
560,798
Tax Provision
41,894
53,485
74,732
81,954
103,780
Net Income Common Stockholders
-256,860
244,241
281,777
211,150
456,356
Diluted NI Available to Com Stockholders
-256,860
244,241
281,777
211,150
456,356
Basic EPS
-
0.0064
0.0072
0.0053
0.0111
Diluted EPS
-
0.0064
0.0072
0.0053
0.0111
Basic Average Shares
-
38,460
38,990
40,155
41,301
Diluted Average Shares
-
38,460
38,990
40,155
41,301
Total Operating Income as Reported
-271,186
246,535
296,193
303,010
514,951
Total Expenses
872,293
398,234
373,700
358,903
364,436
Net Income from Continuing & Discontinued Operation
-256,860
244,241
281,777
211,150
456,356
Normalized Income
-262,065
232,059
261,758
234,860
440,271
Interest Income
20,341
22,655
19,691
19,934
14,468
Interest Expense
3,039
725
256
304
131
Net Interest Income
31,330
33,644
33,542
19,934
14,468
EBIT
-218,961
298,760
357,110
292,672
560,929
EBITDA
-197,078
-
-
-
-
Reconciled Cost of Revenue
238,160
245,044
224,169
198,405
208,136
Reconciled Depreciation
21,883
21,383
18,597
16,496
14,829
Net Income from Continuing Operation Net Minority Interest
-256,860
244,241
281,777
211,485
456,708
Total Unusual Items Excluding Goodwill
7,130
14,838
25,309
-32,465
20,168
Total Unusual Items
7,130
14,838
25,309
-32,465
20,168
Normalized EBITDA
-204,208
305,305
350,398
341,633
555,590
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,925
2,656
5,290
-9,090
3,731